mpany in 2001 and previously served as director of Method Development and Validation at MDS Pharma Services' early clinical research and bioanalysis facility in Lincoln, Nebraska.His clinical therapeutic experience includes rheumatoid arthritis, lupus and other autoimmune diseases; cancer, neurodegenerative diseases such as Alzheimer's Disease and Parkinson's Disease; diabetes, atherosclerosis, ps